EUVIMEDEUVIMED entdecken
Kohortenstudie

The Association of Persistent Hyperuricemia With Liver Function and the Management of Uric Acid Levels: Insights From a Three‐Year Prospective Cohort Study

Yina Wang, Minli Qiu iD, Liuzhong Zhou, Xuqi Zheng iD, Xinyu Wu, Liudan Tu, Ya Xie, Mingcan Yang, Linkai Fang, Xianghui Wen, Boxiong Jiang, Jieruo Gu

International Journal of Rheumatic Diseases · 2025

DOI: 10.1111/1756-185x.70079 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Yina Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of VIP Medical Center, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China. Hauptthemen laut MEDLINE: Hyperuricemia, Uric Acid, Liver. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Guangdong Clinical Research Center of Immune disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The association of long‐term hyperuricemia with liver function remains less well understood. This prospective cohort study aimed to investigate the relationship between hyperuricemia and liver function as well as other metabolic and cardiovascular parameters.

Methods

We enrolled 375 participants with hyperuricemia and 599 normouricemic controls. Participants were followed up for 3 years, and data on liver indicators, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), and liver ultrasonography were collected. Additionally, we assessed other parameters, such as renal function, lipid profile, blood pressure, fasting blood‐glucose (FBG), and body mass index (BMI).

Results

The highest prevalence of hyperuricemia was observed in the 20–29 age groups for the participants. Among the comorbidities of patients with hyperuricemia, the proportion of dyslipidemia is the highest (58.13%), followed by fatty liver (50.13%) and liver function impairment (33.07%). During the three‐year follow‐up period, compared to the baseline, patients with persistent hyperuricemia showed significant increases in BMI, triglycerides, total cholesterol, AST, and ALT levels ( p < 0.05). Meanwhile, patients with improved hyperuricemia for 2 years exhibited significant decreases in FBG, total cholesterol, serum creatinine ( p < 0.05), along with a significant increase in eGFR ( p < 0.05). Correlation analysis revealed that levels of uric acid were positively correlated with ALT, FBG, and triglycerides in persistent hyperuricemia (p < 0.05).

Conclusion

Hyperuricemia shows a notable trend of younger age onset. Persistent hyperuricemia, correlated with elevated ALT levels, indicates an increasing risk of liver damage that should be concerned about. Effective management of hyperuricemia could improve metabolic disorders and renal dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperuricemiaUric AcidLiverHumansMaleFemaleProspective StudiesMiddle AgedAdultBiomarkersTime FactorsPrevalenceRisk FactorsYoung AdultChinaCase-Control StudiesLiver Function TestsAged

Stichwörter der Autor:innen

dyslipidemiahyperuricemialiver functionmanagementmetabolic disordersprospective cohort study

Substanzen

Uric AcidBiomarkers

Autor:innen und Institutionen

  • Department of VIP Medical Center, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
  • Department of Rheumatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
  • Shenzhen Longhua Institute of Immunology Transformation, Shenzhen, Guangdong Province, China.

ORCID-Profile: Minli Qiu, Xuqi Zheng

Förderung

  • Guangdong Clinical Research Center of Immune disease

Zitieren

APA

Wang, Y., Qiu, M., Zhou, L., Zheng, X., Wu, X., Tu, L., Xie, Y., Yang, M., Fang, L., Wen, X., Jiang, B., & Gu, J. (2025). The Association of Persistent Hyperuricemia With Liver Function and the Management of Uric Acid Levels: Insights From a Three‐Year Prospective Cohort Study. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70079

Vancouver

Wang Y, Qiu M, Zhou L, Zheng X, Wu X, Tu L, et al. The Association of Persistent Hyperuricemia With Liver Function and the Management of Uric Acid Levels: Insights From a Three‐Year Prospective Cohort Study. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70079

BibTeX
@article{Wang2025,
  author = {Wang, Yina and Qiu, Minli and Zhou, Liuzhong and Zheng, Xuqi and Wu, Xinyu and Tu, Liudan and Xie, Ya and Yang, Mingcan and Fang, Linkai and Wen, Xianghui and Jiang, Boxiong and Gu, Jieruo},
  title = {The Association of Persistent Hyperuricemia With Liver Function and the Management of Uric Acid Levels: Insights From a Three‐Year Prospective Cohort Study},
  journal = {International Journal of Rheumatic Diseases},
  year = {2025},
  doi = {10.1111/1756-185x.70079}
}
Kostenlos starten →